End-stage renal disease and economic incentives: The International Study of Health Care Organization and Financing (ISHCOF)

被引：61

作者：

Dor A. ^{[1
]}

Pauly M.V. ^{[2
]}

Eichleay M.A. ^{[3
]}

Held P.J. ^{[3
]}

机构：

[1] School of Public Health and Health Services, George Washington University, Washington, DC

[2] Wharton School of Business, University of Pennsylvania, Philadelphia, PA

[3] Arbor Research Collaborative for Health, Ann Arbor, MI

来源：

International Journal of Health Care Finance and Economics | 2007年 / 7卷 / 2-3期

关键词：

Dialysis; End-stage renal disease; Health care financing; Incentives; Medical costs; Reimbursement; Transplantation;

D O I：

10.1007/s10754-007-9024-9

中图分类号：

学科分类号：

摘要：

End-stage renal disease (ESRD) is a debilitating, costly, and increasingly common condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care. This paper presents results from a comparative review of 12 countries with alternative models of incentives and benefits, collected under the International Study of Health Care Organization and Financing, a substudy within the Dialysis Outcomes and Practice Patterns Study. Variation in spending per ESRD patient is relatively small, but correlated with overall per capita health care spending. Remaining differences in costs and outcomes do not seem strongly linked to differences in incentives. © Springer Science+Business Media, LLC 2007.

引用

页码：73 / 111

页数：38

共 86 条

[1]

Ansell D., Feest T., UK Renal Registry Report 1999, (1999)

[2]

Ansell D., Feest T., Byrne C., Ahmad A., UK Renal Registry Report 2003, (2003)

[3]

Aron D.C., Harper D.L., Shepardson L.B., Rosenthal G.E., Impact of risk-adjusting cesarean delivery rates when reporting hospital performance, Journal of the American Medical Association, 279, 24, pp. 1968-1972, (1998)

[4]

Ashton T., Marshall M.R., The organization and financing of dialysis and kidney transplantation services in New Zealand, International Journal of Health Care Finance and Economics, (2007)

[5]

Registry Report, (2005)

[6]

Birkmeyer J.D., Sharp S.M., Finlayson S.R., Fisher E.S., Wennberg J.E., Variation profiles of common surgical procedures, Surgery, 124, pp. 917-923, (1998)

[7]

Birkmeyer J.D., Siewers A.E., Finlayson E.V.A., Stukel T.A., Lucas F.L., Batista I., Welch H.G., Wennberg D.E., Hospital volume and surgical mortality in the United States, New England Journal of Medicine, 346, pp. 1128-1137, (2002)

[8]

Brooks J.M., Irwin C.P., Hunsicker L.G., Flanigan M.J., Chrischilles E.A., Pendergast J.F., Effect of dialysis center profit-status on patient survival: A comparison of risk-adjustment and instrumental variable approaches, Health Services Research, 41, 6, pp. 2267-2289, (2006)

[9]

Treatment of End-stage Organ Failure in Canada 2002 and 2003, (2005)

[10]

Cass A., Chadban S., Craig J., Howard K., McDonald S., Salkeld G., White S., The Economic Impact of End Stage Kidney Disease in Australia, (2006)

← 1 2 3 4 5 6 7 8 9 →